2-Phenyl-1-ethynylboronic acid pinacol ester
Product Information
Molecular Formula
C14H17BO2
Molecular Weight
228.1
Description
2-Phenyl-1-ethynylboronic acid pinacol ester has potential antiviral and anticancer properties and can be applied in drug development against viral infection and cancer cell growth. This compound molecule plays a crucial role in inhibiting the proliferation of specific pathogens and malignant cells.
Synonyms
4,4,5,5-Tetramethyl-2-(phenylethynyl)-1,3,2-dioxaborolane
IUPAC Name
4,4,5,5-tetramethyl-2-(2-phenylethynyl)-1,3,2-dioxaborolane
SMILES
B1(OC(C(O1)(C)C)(C)C)C#CC2=CC=CC=C2
InChI
InChI=1S/C14H17BO2/c1-13(2)14(3,4)17-15(16-13)11-10-12-8-6-5-7-9-12/h5-9H,1-4H3
InChI Key
VEIORNIWTVJLCN-UHFFFAOYSA-N
Melting Point
49-68 °C
Flash Point
Not applicable
Purity
95%
Appearance
white to tan solid
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
2
Exact Mass
228.1321599 g/mol
Monoisotopic Mass
228.1321599 g/mol
Topological Polar Surface Area
18.5Ų
Heavy Atom Count
17
Formal Charge
0
Complexity
326
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022006457-A1 | Tricyclic urea compounds as jak2 v617f inhibitors | 2020-07-02 |
| WO-2020059824-A1 | Boron-containing conjugated polyene compound, method for producing same, and method for producing conjugated polyene compound | 2018-09-19 |
| CN-112714767-A | Boron-containing conjugated polyene compound, process for producing the same, and process for producing conjugated polyene compound | 2018-09-19 |
| JP-WO2020059824-A1 | A boron-containing conjugated polyene compound and a method for producing the same, and a method for producing the conjugated polyene compound. | 2018-09-19 |
| CN-107573336-B | Benzoheterocycle-formamide-pyridone derivative and preparation method and application thereof | 2016-07-05 |
| KR-101759774-B1 | A method for preparing core-shell copper nanoparticlesimmobilized on activated carbonandthe preparation of chalcogenide compoundusing them as a catalyst | 2015-04-21 |
| KR-20160125181-A | A method for preparing core-shell copper nanoparticlesimmobilized on activated carbonandthe preparation of chalcogenide compoundusing them as a catalyst | 2015-04-21 |
| US-2016311768-A1 | Method of preparing core-shell copper nanoparticles immobilized on activated carbon and method of preparing chalcogenide compound using nanoparticles as catalyst | 2015-04-21 |
| US-9518012-B2 | Method of preparing core-shell copper nanoparticles immobilized on activated carbon and method of preparing chalcogenide compound using nanoparticles as catalyst | 2015-04-21 |
| EP-2876109-A1 | Fused ring compound containing furan or salt thereof and pharmaceutical composition comprising same | 2012-07-23 |
